FDA Calls for Stronger Warnings on 4 Crohn's Disease Drugs
Today the FDA called for stronger warning labels on four of the largest selling Crohn's disease drugs: Remicade, Humira, Enbrel, and Cimzia. The call for stricter warning labels are a result of the increased risk of serious fungal infections associated with the drugs. Specifically, the FDA reported 240 cases of histoplasmosis in patients... Read more
